CH577499A5 - - Google Patents

Info

Publication number
CH577499A5
CH577499A5 CH1597672A CH1597672A CH577499A5 CH 577499 A5 CH577499 A5 CH 577499A5 CH 1597672 A CH1597672 A CH 1597672A CH 1597672 A CH1597672 A CH 1597672A CH 577499 A5 CH577499 A5 CH 577499A5
Authority
CH
Switzerland
Application number
CH1597672A
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH577499A5 publication Critical patent/CH577499A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1597672A 1971-11-03 1972-11-02 CH577499A5 (OSRAM)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (1)

Publication Number Publication Date
CH577499A5 true CH577499A5 (OSRAM) 1976-07-15

Family

ID=27257588

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1597672A CH577499A5 (OSRAM) 1971-11-03 1972-11-02

Country Status (17)

Country Link
US (1) US3884919A (OSRAM)
JP (1) JPS4856667A (OSRAM)
AR (3) AR198064A1 (OSRAM)
BE (1) BE790679A (OSRAM)
CA (1) CA983932A (OSRAM)
CH (1) CH577499A5 (OSRAM)
DD (1) DD105611A5 (OSRAM)
DE (1) DE2253927A1 (OSRAM)
EG (1) EG11358A (OSRAM)
ES (2) ES408226A1 (OSRAM)
FR (1) FR2158464B1 (OSRAM)
GB (1) GB1356834A (OSRAM)
HU (1) HU169711B (OSRAM)
IE (1) IE37998B1 (OSRAM)
IL (1) IL40521A (OSRAM)
NL (1) NL7214807A (OSRAM)
SE (1) SE384856B (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
KR100225721B1 (ko) * 1994-02-23 1999-10-15 디. 제이. 우드, 스피겔 알렌 제이 4-헤테로사이클릴-치환된 퀴나졸린 유도체, 이들의 제조 방법 및항암제로서의 용도
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
JP2002504541A (ja) * 1998-02-25 2002-02-12 ジェネティックス・インスチチュート・インコーポレーテッド ホスホリパーゼ酵素阻害剤
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301010D0 (sv) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
DK1471057T3 (da) 2003-04-25 2006-05-15 Actimis Pharmaceuticals Inc Pyrimidinyleddikesyrederivater, der er egnede til behandlingen af sygdomme medieret af CRTH2
ES2290743T3 (es) * 2003-04-30 2008-02-16 The Institutes For Pharmaceutical Discovery, Llc Heteroarilos sustituidos como inhibidores de las proteina-tirosina fosfatasas.
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
NZ548396A (en) 2004-01-31 2010-06-25 Actimis Pharmaceuticals Inc Imidazo[1,2-C]pyrimidinylacetic acid derivatives
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
US8524715B2 (en) 2004-11-23 2013-09-03 Astrazeneca Ab Phenoxyacetic acid derivatives useful for treating respiratory diseases
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
EP1937632A1 (en) 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
CN101454284A (zh) 2006-05-26 2009-06-10 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
EP2046740B1 (en) 2006-07-22 2012-05-23 Oxagen Limited Compounds having crth2 antagonist activity
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
KR20100061746A (ko) 2007-09-25 2010-06-08 액티미스 파마수티컬스 인코포레이티드 Crth2 길항제로서의 2-s-벤질 치환된 피리미딘
PT2205569E (pt) 2007-09-25 2012-05-25 Actimis Pharmaceuticals Inc Alquiltiopirimidinas como antagonistas de crth2
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
MX2010007833A (es) 2008-01-18 2010-08-11 Oxagen Ltd Compuestos que tienen actividad antagonista de crth2.
JP2011509990A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Crth2アンタゴニスト活性を有する化合物
EP2240444A1 (en) 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
JP2022512588A (ja) * 2018-10-05 2022-02-07 バーテックス ファーマシューティカルズ インコーポレイテッド アルファ1アンチトリプシンのモジュレーター

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (OSRAM) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
AR203627A1 (es) 1975-09-30
IL40521A (en) 1975-06-25
FR2158464B1 (OSRAM) 1976-07-02
AR198064A1 (es) 1974-05-31
IE37998B1 (en) 1977-12-07
DE2253927A1 (de) 1973-05-10
HU169711B (OSRAM) 1977-02-28
EG11358A (en) 1977-02-28
CA983932A (en) 1976-02-17
JPS4856667A (OSRAM) 1973-08-09
AR203626A1 (es) 1975-09-30
US3884919A (en) 1975-05-20
SE384856B (sv) 1976-05-24
IL40521A0 (en) 1972-12-29
NL7214807A (OSRAM) 1973-05-07
FR2158464A1 (OSRAM) 1973-06-15
ES408226A1 (es) 1976-02-01
DD105611A5 (OSRAM) 1974-05-05
BE790679A (fr) 1973-04-27
ES437311A1 (es) 1977-04-01
GB1356834A (en) 1974-06-19
IE37998L (en) 1973-05-03

Similar Documents

Publication Publication Date Title
FR2158464B1 (OSRAM)
ATA136472A (OSRAM)
AR196074A1 (OSRAM)
BE776170A (OSRAM)
AU2691671A (OSRAM)
AU2726271A (OSRAM)
AU2894671A (OSRAM)
AU2742671A (OSRAM)
AU2485671A (OSRAM)
AU2684071A (OSRAM)
AU2455871A (OSRAM)
AU2724971A (OSRAM)
AU2399971A (OSRAM)
AU2963771A (OSRAM)
AU2415871A (OSRAM)
AU2885171A (OSRAM)
AU2875571A (OSRAM)
AR199640Q (OSRAM)
AU1109576A (OSRAM)
AU2836771A (OSRAM)
AU2755871A (OSRAM)
AU2669471A (OSRAM)
AU2456871A (OSRAM)
AR192311Q (OSRAM)
AU2837671A (OSRAM)

Legal Events

Date Code Title Description
PL Patent ceased